Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial

Radiotherapy and Oncology

Volumn 117, Issue 1, 2015, Pages 44-48

  Louie, Alexander V ^a,b   Van Werkhoven, Erik ^c   Chen, Hanbo ^b   Smit, Egbert F ^a   Paul, Marinus A ^a   Widder, Joachim ^d   Groen, Harry J M ^d   Van Den Borne, Ben E E M ^e   De Jaeger, Katrien ^e   Slotman, Ben J ^a   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

Author keywords

Lung cancer; Patient reported outcomes; Quality of life; SABR; SBRT; Surgery

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; HUMAN; MULTICENTER STUDY; NON SMALL CELL LUNG CANCER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC TREATMENT; STEREOTAXIC SURGERY; TREATMENT OUTCOME; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; LUNG NEOPLASMS; LUNG SURGERY; PATHOLOGY; RADIOSURGERY; SELF REPORT;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PULMONARY SURGICAL PROCEDURES; QUALITY OF LIFE; RADIOSURGERY; SELF REPORT; TREATMENT OUTCOME;

EID: 84945555605     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.08.011     Document Type: Article

References (26)

1. J. Vansteenkiste, D. De Ruysscher, W.E. Eberhardt, E. Lim, S. Senan, E. Felip, and et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 24 2013 vi89 vi98
2. A.V. Louie, D.A. Palma, M. Dahele, G.B. Rodrigues, and S. Senan Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons Radiother Oncol 114 2015 138 147
3. A.V. Louie, S. Senthi, and D.A. Palma Surgery versus SABR for NSCLC Lancet Oncol 14 2013 e491
4. N.E. Verstegen, J.W. Oosterhuis, D.A. Palma, G. Rodrigues, F.J. Lagerwaard, A. van der Elst, and et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis Ann Oncol 24 2013 1543 1548
5. S. Mokhles, J.J. Nuyttens, A.P. Maat, O. Birim, J.G. Aerts, A.J. Bogers, and et al. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis Ann Surg Oncol 22 2015 316 323
6. J.Y. Chang, S. Senan, M.A. Paul, R.J. Mehran, A.V. Louie, P. Balter, and et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Lancet Oncol 2015
7. C.W. Hurkmans, J.P. Cuijpers, F.J. Lagerwaard, J. Widder, U.A. van der Heide, D. Schuring, and et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study Radiat Oncol 4 2009 1
8. M.A. Sprangers, A. Cull, K. Bjordal, M. Groenvold, and N.K. Aaronson The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life Qual Life Res 2 1993 287 295
9. N.K. Aaronson, S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull, N.J. Duez, and et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
10. B. Bergman, N.K. Aaronson, S. Ahmedzai, S. Kaasa, and M. Sullivan The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life Eur J Cancer 30A 1994 635 642
11. D.F. Cella, A.E. Bonomi, S.R. Lloyd, D.S. Tulsky, E. Kaplan, and P. Bonomi Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument Lung Cancer 12 1995 199 220
12. Haakkart-van Roijen L, Bouwmans C. Short Form - Health and Labour Questionnaires (SF-HLQ). 2010. Available at: < http://www.bmg.eur.nl/fileadmin/ASSETS/bmg/english/iMTA/Publications/Manuals--Questionnaires/Manual-SF-HLQ-2010.pdf > Accessed May 2015.
13. P.M. Fayers, N.K. Aaronson, K. Bjordal, M. Groenvold, D. Curran, and A. Bottomley The EORTC QLQ-C30 scoring manual III ed. 2001 European Organisation for Research and Treatment of Cancer Brussels, Belgium
14. D. Osoba, G. Rodrigues, J. Myles, B. Zee, and J. Pater Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 16 1998 139 144
15. M.A. Koopmanschap, F.F. Rutten, B.M. van Ineveld, and L. van Roijen The friction cost method for measuring indirect costs of disease J Health Econ 14 1995 171 189
16. H. Poghosyan, L.K. Sheldon, S.G. Leveille, and M.E. Cooley Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review Lung Cancer 81 2013 11 26
17. P.M. Kenny, M.T. King, R.C. Viney, M.J. Boyer, C.A. Pollicino, J.M. McLean, and et al. Quality of life and survival in the 2 years after surgery for non small-cell lung cancer J Clin Oncol 26 2008 233 241
18. S. Gazala, J.S. Pelletier, D. Storie, J.A. Johnson, D.J. Kutsogiannis, and E.L. Bedard A systematic review and meta-analysis to assess patient-reported outcomes after lung cancer surgery Sci World J 2013 2013 789625
19. R.J. Ubels, S. Mokhles, E.R. Andrinopoulou, C. Braat, N.C. van der Voort van Zyp, S. Aluwini, and et al. Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer Radiat Oncol 10 2015 98
20. A.V. Louie, G. Rodrigues, M. Hannouf, G.S. Zaric, D.A. Palma, J.Q. Cao, and et al. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis Int J Radiat Oncol Biol Phys 81 2011 964 973
21. S.M. Shirvani, J. Jiang, J.Y. Chang, J. Welsh, A. Likhacheva, T.A. Buchholz, and et al. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly JAMA Surg 2014
22. J.B. Yu, P.R. Soulos, L.D. Cramer, R.H. Decker, A.W. Kim, and C.P. Gross Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer Cancer 2015
23. L.E. Schnipper, N.E. Davidson, D.S. Wollins, C. Tyne, D.W. Blayney, D. Blum, and et al. American society of clinical oncology statement: a conceptual framework to assess the value of cancer treatment options J Clin Oncol 2015
24. A. Shah, S.M. Hahn, R.L. Stetson, J.S. Friedberg, T.T. Pechet, and D.J. Sher Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer Cancer 119 2013 3123 3132
25. A.V. Louie, G.B. Rodrigues, D.A. Palma, and S. Senan Measuring the population impact of introducing stereotactic ablative radiotherapy for stage i non-small cell lung cancer in Canada Oncologist 2014
26. W. Hopmans, L. Zwaan, S. Senan, I. van der Wulp, O.C. Damman, K.J. Hartemink, and et al. Differences between pulmonologists, thoracic surgeons and radiation oncologists in deciding on the treatment of stage I non-small cell lung cancer: a binary choice experiment Radiother Oncol 115 2015 361 366